By: S. Blitshteyn Published February 2010 Postural tachycardia syndrome (POTS) is a heterogeneous disorder of the autonomic nervous system, consisting of orthostatic intolerance and an increase in heart rate of more than 30 bpm within 10 min of standing or head-up tilt [1]. Human Papillomavirus Quadrivalent Vaccine, Gardasil, has been approved for prevention of cervical […]
Gardasil – Update on National Marketing Experience
Published 11 November 2010 Adverse events reported through 31 October 2010 in Ireland The HSE human papillomavirus (HPV) School Immunisation Programme commenced in May 2010 and it is estimated that 60,000 doses of Gardasil have been distributed and approximately 45,000 doses have been administered up to the end of October 2010. The Irish Medicines […]
Memo from: DHHS/FDA/CBER
Subject: Gardasil Pediatric Utilization and Safety Review for Pediatric Advisory Committee Meeting On June 8, 2006, the US Food and Drug Administration approved the first vaccine against the human papillomavirus (HPV). Gardasil was initially licensed for females aged 9–26 years for the prevention of cervical cancer and precancerous lesions, as well as genital warts […]
November 11, 2010 Analysis of VAERS Reports
Found 21,022 events where Vaccine is HPV, HPV2, and HPV4. All HPV VACCINES COMBINED Found 89 events where Vaccine is HPV, HPV2, and HPV4 and Patient Died. View report here.
PATIENT INFORMATION ABOUT GARDASIL
What important information about GARDASIL should I know? You should continue to get routine cervical cancer screening. GARDASIL may not fully protect everyone who gets the vaccine. GARDASIL will not protect against HPV types that you already have. Who should not get GARDASIL? You should not get GARDASIL if you have, or have had: […]